Mutated coronavirus can learn to enter cells in a new way

Researchers at the University of Washington School of Medicine in St. Louis found that one mutation allows SARS-CoV-2 to enter cells without the involvement of the ACE2 receptor.

At the very beginning of the COVID-19 pandemic, scientists figured out how the SARS-CoV-2 virus enters cells and causes infection – using the ACE2 receptor. All current novel coronavirus vaccines and antibody-based therapies are designed to disrupt this cell entry pathway.

However, in a new study, the researchers found that one mutation gives SARS-CoV-2 the ability to enter cells in a different way that does not require ACE2. It looks like the virus can suddenly change and find new ways to infect the body. The study is published in the journal Cell Reports.

It is unclear if an alternative pathway comes into play in real life when people are infected with SARS-CoV-2. Before researchers can figure this out, they must find an alternative receptor that the virus uses to enter cells.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: John Kessler
Graduated From the Massachusetts Institute of Technology. Previously, worked in various little-known media. Currently is an expert, editor and developer of Free News.
Function: Director
John Kessler

Spelling error report

The following text will be sent to our editors:

36 number 0.301700 time